Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.43 INR | +0.59% | -.--% | -21.15% |
2022 | R J Biotech Limited Auditor Raises 'Going Concern' Doubt | CI |
2022 | R J Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2022 | CI |
Sales 2021 | 158M 1.89M | Sales 2022 | 139M 1.66M | Capitalization | 48.95M 586K |
---|---|---|---|---|---|
Net income 2021 | -157M -1.88M | Net income 2022 | -91M -1.09M | EV / Sales 2021 | 2.97 x |
Net Debt 2021 | 405M 4.85M | Net Debt 2022 | 511M 6.12M | EV / Sales 2022 | 4.03 x |
P/E ratio 2021 |
-0.41
x | P/E ratio 2022 |
-0.53
x | Employees | 110 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 39.68% |
1 day | +0.59% | ||
3 months | -20.60% | ||
6 months | -21.33% | ||
Current year | -21.15% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 40 | 20-06-30 | |
Compliance Officer | - | 22-01-10 | |
Dnyaneshwar Kale
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 43 | 21-03-04 | |
Chairman | - | 19-06-13 | |
Director/Board Member | - | 19-01-04 |
- Stock Market
- Equities
- RJBIOTECH6 Stock